To study complications and sequelae of serogroup B and C meningococcal disease, a retrospective survey examined the outcome of all culture-proven cases reported in the province of Quebec, Canada, from January 1990 through December 1994 (serogroup B, 167 cases; serogroup C, 304 cases). Data were collected from medical files, postal questionnaires, and telephone interviews. Age groups having the most cases were the 10 -19-year age group for serogroup C and the õ1-year age group for serogroup B. Fatality rates were 7% for serogroup B and 14% for serogroup C disease. Only 3% of survivors of serogroup B disease had physical sequelae, compared with 15% of survivors of serogroup C disease (skin scars, 12%; amputations, 5%; hearing loss, 2%; renal problems, 1%; and other sequelae, 4%). These results confirm the gravity of disease caused by serogroup C, serotype 2a Neisseria meningitidis and justify liberal use of vaccination for outbreak control.
An increase in incidence of meningococcal disease began in assesses the rate of complications, deaths, and physical and psychological sequelae in cases of serogroup B and C meningo-the province of Quebec, Canada, in 1990 and was associated with the emergence of a virulent strain of serogroup C, serotype coccal disease reported in the province of Quebec from 1990 through 1994. The quality of life of survivors was also evalu-2a Neisseria meningitidis [1] . Similar strains were responsible for outbreaks in other areas in North America [2, 3] and in ated, by means of both objective and subjective scoring systems. Europe [4 -6] .
In 1992, local and regional immunization campaigns were carried out in several regions of the province of Quebec, but Study Population and Methods outbreaks continued to occur. A mass vaccination program was undertaken in early 1993, reaching 84% of the target population Meningococcal disease is a notifiable disease in Quebec. (aged 6 months to 20 years) at a cost of Ç$25.5 million CAD Cases diagnosed by clinicians and laboratories are reported to [7] . In the first year following the campaign, the incidence of the regional health board, which gathers administrative and serogroup C meningococcal disease dropped markedly among epidemiological information, including date of occurrence, labthose vaccinated and also in the unvaccinated fraction of the oratory confirmation of the diagnosis, and serogroup of the target population, while it remained unchanged among persons bacteria. Since 1990, reports have been entered into a provincial aged ú20 years. This observation suggests a slowing down in registry; since 1993, the information routinely collected has the transmission of the bacteria, as a result of the immunization included symptoms, clinical diagnosis, and complications. In campaign. At least 37 cases were prevented during the first a majority of cases diagnosed by bacterial culture, a specimen year as a result of the direct efficacy of the vaccine, and an is sent to the provincial reference laboratory for confirmation estimated 26 additional cases were prevented as a consequence and classification of the bacterial strain. When a strain isolated of herd immunity [7] . During the 1990 -1994 period, serogroup from a patient is received at the reference laboratory, the case B meningococcal disease remained endemic.
is reported to the regional health board concerned. A thorough analysis of the health impacts of meningococcal The provincial central registry was reviewed to identify all disease is required to evaluate actual and potential benefits of confirmed cases of serogroup B and C meningococcal disease immunization and to guide public health policy. This study occurring between 1 January 1990 and 31 December 1994. Information on identified cases was gathered from the records of the 17 regional health boards and the provincial reference laboratory. Survivors (or their parents or guardians) were con-additional information on complications and sequelae. After problems, and psychosocial impairment stemming from the disease. Those considering their recovery to be incomplete exclusion of refusals, permission was requested to access medical files in the 91 hospitals where patients were treated (con-were asked to note their degree of agreement (on a five-point scale) with 12 statements concerning different aspects of qual-senting survivors, survivors who were not successfully located, and deceased persons).
ity of life. The categories were energy, anxiety, social and leisure activ-A case was defined by the culture-proven presence of meningococci in normally sterile sites such as blood, CSF, or synovial ities, quality of family life, physical appearance, ability to learn and solve problems, general satisfaction with life, and, when fluid. There were no cases in which the diagnosis was made solely on the basis of antigen detection. Cases were classified applicable, capacity to do housework, drive an automobile, work, and study. An overall ad hoc impairment score was then in different clinical categories on the basis of combined clinical and laboratory data. Meningitis was defined by a CSF culture calculated as a percentage of the maximum possible score. This gave an index of the magnitude of reduction of quality of positive for N. meningitidis, by the presence of microscopic or biochemical signs of inflammation in the CSF, or by specific life as noted by the individual in the questionnaire (0% Å no impairment; 100% Å maximum impairment). clinical signs of cerebromeningeal irritation (e.g., stiff neck, Kernig's or Brudzinski's sign, focal neurological deficits, Univariate comparisons were conducted with use of the x 2 test for categorical variables and Student's t-test for continuous coma, or paralysis).
Septicemia was defined by distinct clinical signs (e.g., shock, variables. Correlation between the two scoring systems was measured by Pearson's R coefficient. This project was approved extended purpura or petechiae, or disseminated intravascular coagulation). Major complications were defined as dissemin-by the Provincial Commission for Access to Information and the Ethics Committee of the Sherbrooke University Hospital. ated intravascular coagulation, coma, multiple organ failure, cardiorespiratory arrest, respiratory distress syndrome, extensive necrosis or gangrene, pericarditis, and death. Minor complications were defined as anemia, arthritis, temporary neural Results perturbations, or other minor problems.
A total of 471 cases were identified, 167 of serogroup B In addition to determining the frequency of sequelae, we infection and 304 of serogroup C infection. Among serogroup wanted an index of their relative severity. The Annotated Scale C strains that were characterized at the reference laboratory, of Bodily Injuries Regulation (a scale used by the Quebec 93% (207 of 233) were of serotype 2a and 89% (201 of 226) Occupational Health and Safety Commission [OHSC] for were of electrophoretic type 15. Forty-nine percent of infecwork-related injuries) was used to calculate an overall score tions with each serogroup were in males. The average age of of permanent mental/physical impairment [8] . The physical patients was 13.5 years (median, 2 years) for serogroup B and impairment score is widely used in the province and is compre-17.6 years (median, 14 years) for serogroup C (P õ .05). The hensive, taking account of anatomic and physiologic deficits, distribution across age groups was different between serodisfigurement, and suffering or loss of enjoyment of life regroups B and C. Age groups having the most cases were the sulting from the deficit or disfigurement. The score is expressed 10 -19-year age group for serogroup C and the 0 -1-year age as a percentage of physical impairment, which increases with group for serogroup B (table 1) . increasing severity of permanent injury.
An impairment score of 100% normally provides for compensation equivalent to full salary. Because scores for different Table 4 gives details on retraced because of address changes. Of the individuals contacted, 96% participated in the study and 4% refused to partici-survivors with amputations. A total of 11 survivors with postnecrotic scarring received skin grafts, all of whom had serogroup pate or did not respond. On the average, participants completed the questionnaire 38 months after occurrence of the disease C disease. Of the three serogroup C disease survivors with permanent renal problems, one received a kidney transplant (range, 9 to 72 months). The hospital record was reviewed for 91% of the cases (430 of 471). Four rapidly fatal cases and three and the other two had temporary dialysis and permanent minor reduction in kidney function. very mild cases did not involve hospitalization. Permission to review records was not obtained for 33 cases, and the record To assess hearing loss, overall decibel thresholds (the average of thresholds obtained at 500, 1,000 and 2,000 Hz) were of another patient was not found by the hospital concerned.
Classification of cases in different clinical categories was calculated from results of audiometric tests. One serogroup B survivor had significant bilateral impairment (70 dB right; 30 possible for 452 cases (96%) (table 2). Fifteen cases met neither the criteria for septicemia nor those for meningitis; two of them dB left), necessitating use of a hearing aid. One serogroup C survivor had significant unilateral impairment (70 dB right). were only septic arthritis. The 13 remaining cases were of bacteremia with nonspecific symptoms of infection. Septicemia
The remaining six cases for both serogroups involved only minor (õ45-dB) unilateral hearing impairment. All cases with with or without meningitis represented 79% of serogroup B and 88% of serogroup C cases (P õ .05). There was no significant hearing loss met our criteria for the diagnosis of meningitis. Three survivors of serogroup C disease had permanent knee variation in the proportion of septicemic patients according to age for both serogroups B and C.
damage following septic arthritis causing mild reduction in mobility. Three survivors of serogroup B disease (of whom The fatality rate was 7% (12 of 167 cases) for serogroup B and 14% (42 of 304 cases) for serogroup C disease. Including two also had hearing loss) and three survivors of serogroup C disease (none of whom had hearing loss) had speech problems. deaths, 12% of serogroup B cases and 30% of serogroup C cases involved major complications. When minor complica-One survivor of serogroup C disease developed multiple neural deficits (including partial paralysis and loss of central vision) tions are included, 37% of serogroup B cases vs. 59% of serogroup C cases had at least one complication. These differences following an intracerebral hemorrhage. Other problems of serogroup C survivors were ankylosis of fingers (n Å 1) and motor are statistically significant (P õ .05).
The effect of age on mortality and complications can also neural damage (n Å 2). Other problems of serogroup B survivors were permanent partial sensory nerve loss of the foot (one be analyzed by stratifying the study population into age groups (figure 1). Although numbers in certain age groups are small, case) and reduced bone growth in an infant that resulted in asymmetry of the legs and necessitated corrective surgery. some patterns are evident. For serogroup C cases, the maximum mortality and morbidity are seen in the 20 -59-year age group, Among those with sequelae, the average physical impairment score was 39% for serogroup B cases (range, 2% -128%) and while a U-shaped distribution is observed for serogroup B cases, with maximum mortality and morbidity at the upper and 55% for serogroup C cases (range, 1% -413%). The worst case involved amputation of two legs (below the knee) and one lower extremes of the age scale.
There was enough information to objectively assess sequelae forearm, as well as scarring over 70% of the body. For serogroup C cases, amputations contributed to 53% of the total of in 420 survivors. Three percent of serogroup B cases (5 of 158) and 15% of serogroup C cases (40 of 262) were affected physical impairment scores, compared with 30% for skin scars and only 1% for hearing loss. Among the 231 persons who completed the questionnaire, 23% (21% of serogroup B -infected patients and 24% of sero- The main weakness of the present study is its retrospective (20% in serogroup B cases and 19% in serogroup C cases). and cross-sectional design. Medical files were consulted in 91 different hospitals, in which there was a large variation in Discussion diagnostic tests used and the quality and completeness of medical records. It was therefore difficult to apply rigid, uniform This study has provided valuable information regarding the criteria to define complications and sequelae, and assessment frequency of complications and sequelae of meningococcal diswas often based on results of nonstandardized tests and notes ease. It is the first study to examine the impact of the disease in medical files. on survivors by an objective physical injury scale as well as
The results of this study confirm the severity of serogroup a subjective psychosocial function score. The results allow C serotype 2a meningococcal disease. In developed countries, comparison of serogroup B with serogroup C meningococcal fatality rates associated with meningococcal disease are generdisease.
ally from 7% to 10% [12] . We observed a fatality rate of 7% The study included culture-proven cases of meningococcal for serogroup B and 14% for serogroup C disease. This agrees disease reported in the province of Quebec during the years with the findings of other studies of serogroup C disease [2, 1990 -1994 . During this period of recrudescence, physicians 4, 6, 13]. were especially attentive to notification. In addition, any iso-
The pathogenic potential of a meningococcal strain is related to certain surface organelles and secretions [14] . The capsular polysaccharides, pili, outer membrane vesicles containing lipo-coccal disease, data should be routinely collected on the outcome of reported cases, including deaths and type of sequelae polysaccharides (the ''endotoxin''), and outer membrane proteins including IgA-protease certainly play a role in the inva-at hospital discharge. The exceptional virulence of the serogroup C serotype 2a N. meningitidis supports a liberal use of sion of the human host, multiplication of the bacteria, and induction of tissue damage. The reason for the high virulence vaccination for control of disease outbreaks and epidemics. We are currently conducting a cost-effectiveness study to of this particular strain of N. meningitidis is unknown, but the strain is associated with a high frequency of septicemia (87% estimate the incremental cost per quality-adjusted life year gained by the mass vaccination campaign carried out in Quebec of cases in the present series).
The risk of complications of meningococcal disease is usu-in 1993. ally high in the very young and the very old [15] . In the present study, this was indeed the pattern observed in serogroup B cases. However, serogroup C disease produced high rates of with those reported in the literature [21] . In a recent prospective [22] . Changes in epide- 
